Drugs Made In America Acquisition II Corp. Entity Common Stock, Shares Outstanding for Q4 2025

Taxonomy & unit
dei: shares
Description
Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.
Summary
Drugs Made In America Acquisition II Corp. quarterly Entity Common Stock, Shares Outstanding history and growth rate for Q4 2025.
  • Drugs Made In America Acquisition II Corp. Entity Common Stock, Shares Outstanding for the quarter ending November 18, 2025 was 65.6M shares.
Entity Common Stock, Shares Outstanding, Quarterly (shares)

Drugs Made In America Acquisition II Corp. Quarterly Entity Common Stock, Shares Outstanding (shares)

Period Value YoY Chg Change % Date Report Filed
Q4 2025 65.6M Nov 18, 2025 10-Q 2025-11-18
* An asterisk sign (*) next to the value indicates that the value is likely invalid.